Industry Insights

Home » Industry Insights
1902, 2018

ISPE Launches New Online Guidance Document Portal

By |February 19th, 2018|Categories: News, Pharmaceutical, Research and Development|Tags: |0 Comments

The International Society for Pharmaceutical Engineering (ISPE) has announced the launch of its new online Guidance Document Portal. For the first time, the entire library of Guides — including GAMP 5 — can be accessed and [...]

1902, 2018

Colorcon Makes Tablets Easier to Swallow with Innovative Coating System 

By |February 19th, 2018|Categories: News, Pharmaceutical, Raw Materials and Ingredients|Tags: |0 Comments

Dysphagia is a common ailment often experienced by the geriatric population. Opadry EZ Easy Swallow Film Coating System, a new innovative product from Colorcon Inc., directly addresses the difficulty faced by many patients in swallowing [...]

1602, 2018

Majority of Oncology Clinical Trials in China Failed to Meet Enrolment Targets

By |February 16th, 2018|Categories: Clinical Trials, News, Pharmaceutical|Tags: |0 Comments

The majority of oncology clinical trials in China that had a start date between 1 January 2012 and 31 December 2017 failed to meet the planned enrolment targets, according to GlobalData, a leading data and [...]

1602, 2018

Certara Launches Version 10 of the D360 Drug Discovery Informatics Platform

By |February 16th, 2018|Categories: Analytical, Bioinformatics, News, Pharmaceutical|Tags: |0 Comments

Certara, the global leader in model-informed drug development and regulatory science, has announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and [...]

1502, 2018

Celgene’s Acquisition of Juno Therapeutics Puts the Company in a Good Position to be a Frontrunner in the CAR-T space

By |February 15th, 2018|Categories: Business and Finance, News, Pharmaceutical|Tags: , , |0 Comments

Celgene’s recent announcement of the acquisition of Juno Therapeutics has put the company in a good position to be a frontrunner in the chimeric antigen receptor- T cell (CAR-T) space. Celgene stands to benefit from [...]

1502, 2018

Serialisation Solution Provider Expands Operations in Moscow

By |February 15th, 2018|Categories: News, Pharmaceutical, Regulatory Affairs|Tags: , |0 Comments

Italy based serialisation software provider SEA Vision has expanded its operations in Moscow following the signing of Russia’s track and trace law. SEA Vision, which has more than 20 customers in Russia and has installed [...]